文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

梗阻性黄疸对瑞马唑仑静脉麻醉敏感性的影响:一项对照多中心试验的研究方案

The effect of obstructive jaundice on the sensitivity of intravenous anesthetic of remimazolam: study protocol for a controlled multicenter trial.
PubMed 文献 · Trials · 2022-01-08

本研究为前瞻性、对照、多中心试验,比较梗阻性黄疸患者与非黄疸的慢性胆囊炎或肝内胆管结石患者达到脑电双频指数50所需的瑞马唑仑用量,瑞马唑仑以6 mg/kg/h输注至该终点。作者假设梗阻性黄疸影响瑞马唑仑的药效学,黄疸患者对瑞马唑仑的敏感性增加,旨在证明梗阻性黄疸影响瑞马唑仑药效学且黄疸患者瑞马唑仑剂量应调整。

要点

  • 比较梗阻性黄疸与非黄疸患者达到BIS 50所需的瑞马唑仑用量。
  • 瑞马唑仑以6 mg/kg/h输注至BIS达到50。
  • 作者假设黄疸患者对瑞马唑仑的敏感性增加。

核心结论

  • 作者假设梗阻性黄疸影响瑞马唑仑的药效学,黄疸患者对瑞马唑仑的敏感性增加。
  • 作者旨在证明梗阻性黄疸影响瑞马唑仑的药效学,且梗阻性黄疸患者使用瑞马唑仑时应调整剂量。

研究设计与样本

  • 研究将作为前瞻性、对照、多中心试验实施。
  • 研究设计为比较梗阻性黄疸患者与非黄疸的慢性胆囊炎或肝内胆管结石患者达到脑电双频指数50所需的瑞马唑仑用量。
  • 瑞马唑仑以6 mg/kg/h输注直至达到该终点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is well known that obstructive jaundice could affect the pharmacodynamics of some anesthetics, and the sensitivity of some anesthetics would increase among icteric patients. Remimazolam is a new ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is a high-selective and affinity ligand for the benzodiazepine site on the GABAA receptor. However, no study has reported the pharmacodynamics of remimazolam in patients with obstructive jaundice. We hypothesize that obstructive jaundice affects the pharmacodynamics of remimazolam, and the sensitivity of remimazolam increases among icteric patients. METHODS/DESIGN: The study will be performed as a prospective, controlled, multicenter trial. The study design is a comparison of remimazolam requirements to reach a bispectral index of 50 in patients with obstructive jaundice versus non-jaundiced patients with chronic cholecystitisor intrahepatic bile duct stones. Remimazolam was infused at 6 mg/kg/h until this endpoint was reached. DISCUSSION: Remimazolam could be suitable for anesthesia of patients with obstructive jaundice, because remimazolam is not biotransformed in the liver. Hyperbilirubinemia has been well-described to have toxic effects on the brain, which causes the increasing of sensitivity to some anesthetics, such as desflurane, isoflurane, and etomidate. Furthermore, remimazolam and etomidate have the same mechanism of action when exerting an anesthetic effect. We aim to demonstrate that obstructive jaundice affects the pharmacodynamics of remimazolam, and the dose of remimazolam when administered to patients with obstructive jaundice should be modified. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100043585 . Registered on 23 February 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liu W, Yang B, Ji JW, et al. The effect of obstructive jaundice on the sensitivity of intravenous anesthetic of remimazolam: study protocol for a controlled multicenter trial. Trials. 2022. PMID: 34998423. doi:10.1186/s13063-021-05987-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。